KURA
Price
$6.02
Change
-$0.03 (-0.50%)
Updated
Aug 1 closing price
Capitalization
521.18M
89 days until earnings call
PYXS
Price
$1.10
Change
-$0.02 (-1.79%)
Updated
Aug 1 closing price
Capitalization
68.45M
17 days until earnings call
Interact to see
Advertisement

KURA vs PYXS

Header iconKURA vs PYXS Comparison
Open Charts KURA vs PYXSBanner chart's image
Kura Oncology
Price$6.02
Change-$0.03 (-0.50%)
Volume$1.19M
Capitalization521.18M
Pyxis Oncology
Price$1.10
Change-$0.02 (-1.79%)
Volume$165.19K
Capitalization68.45M
KURA vs PYXS Comparison Chart in %
Loading...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KURA vs. PYXS commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KURA is a Buy and PYXS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (KURA: $6.02 vs. PYXS: $1.10)
Brand notoriety: KURA and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KURA: 99% vs. PYXS: 31%
Market capitalization -- KURA: $521.18M vs. PYXS: $68.45M
KURA [@Biotechnology] is valued at $521.18M. PYXS’s [@Biotechnology] market capitalization is $68.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KURA’s FA Score shows that 1 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • KURA’s FA Score: 1 green, 4 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, both KURA and PYXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KURA’s TA Score shows that 3 TA indicator(s) are bullish while PYXS’s TA Score has 3 bullish TA indicator(s).

  • KURA’s TA Score: 3 bullish, 5 bearish.
  • PYXS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PYXS is a better buy in the short-term than KURA.

Price Growth

KURA (@Biotechnology) experienced а -3.37% price change this week, while PYXS (@Biotechnology) price change was -12.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.14%. For the same industry, the average monthly price growth was +15.55%, and the average quarterly price growth was +36.18%.

Reported Earning Dates

KURA is expected to report earnings on Oct 30, 2025.

PYXS is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KURA($521M) has a higher market cap than PYXS($68.5M). PYXS (-29.487) and KURA (-30.884) have similar YTD gains . PYXS has higher annual earnings (EBITDA): -83.39M vs. KURA (-177.18M). KURA has more cash in the bank: 658M vs. PYXS (105M). KURA (19.4M) and PYXS (19.8M) have identical debt. KURA has higher revenues than PYXS: KURA (68M) vs PYXS (0).
KURAPYXSKURA / PYXS
Capitalization521M68.5M761%
EBITDA-177.18M-83.39M212%
Gain YTD-30.884-29.487105%
P/E RatioN/AN/A-
Revenue68M0-
Total Cash658M105M627%
Total Debt19.4M19.8M98%
FUNDAMENTALS RATINGS
KURA: Fundamental Ratings
KURA
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KURAPYXS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 12 days ago
78%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WMGCX18.03N/A
N/A
Macquarie Mid Cap Growth C
FMUIX14.95N/A
N/A
Federated Hermes Muni and Stock Adv IS
LTAGX15.97N/A
N/A
Lord Abbett International Growth R5
FAOIX37.56N/A
N/A
Fidelity Advisor Overseas I
MEMLX13.96N/A
N/A
Morgan Stanley Inst EMkts Ldrs C

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with PYXS. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then PYXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
-0.50%
PYXS - KURA
65%
Loosely correlated
-1.79%
ZYME - KURA
44%
Loosely correlated
+0.08%
KYMR - KURA
43%
Loosely correlated
-1.81%
ADVM - KURA
42%
Loosely correlated
-2.93%
BEAM - KURA
42%
Loosely correlated
-4.46%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with KURA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
-1.79%
KURA - PYXS
64%
Loosely correlated
-0.50%
BEAM - PYXS
43%
Loosely correlated
-4.46%
RXRX - PYXS
43%
Loosely correlated
-4.54%
ABOS - PYXS
42%
Loosely correlated
-3.57%
BLRX - PYXS
41%
Loosely correlated
-2.76%
More